Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets
  5. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Finance New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...

Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China

Read more
Finance Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human...

Newcells Biotech raises additional funding from investors

Read more
Manufacturing New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

ACG expands global footprint with new capsule manufacturing facility in Thailand

Read more
Finance Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark

Novo Holdings completes acquisition of Catalent

Read more
Regulatory Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist

Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535

Read more
Manufacturing The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's...

£20m Scottish oligonucleotide manufacturing innovation centre now under construction

Read more
Manufacturing This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...

Novo Nordisk invests DKK 8.5bn into new Danish modular production site

Read more
Packaging Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and...

Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger

Read more
Manufacturing The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market

Amgen invests $1bn into new US drug manufacturing facility

Read more
Manufacturing Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support...

Novavax sells protein manufacturing facility to Novo Nordisk for $200m

Read more
Finance The deal makes Biomunex eligible for up to $610m, with Ipsen being responsible for getting the cancer immunotherapy into Phase I clinical trials

Ipsen licenses Biomunex Pharmaceuticals' bispecific antibody, BMX-502

Read more
Manufacturing Baccinex has significant knowledge in sterile fill-finish processes for both lyophilised and liquid vials

CDMO Adragos Pharma acquires aseptic fill-finish manufacturing expert, Baccinex

Read more
Research & Development Through the merger, Roche will acquire Poseida's allogeneic CAR-T cell therapy portfolio, including pre-clinical and clinical-stage iterations for a range of conditions

Roche acquires clinical-stage biopharmaceutical company Poseida Therapeutics

Read more
Manufacturing Three new managing directors to support global sustainable development

Vetter strengthens senior management team for growth

Read more
Finance The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

Read more
Research & Development The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around...

Syncona launches early-stage drug development company, Slingshot Therapeutics

Read more